Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic consequences of exogenous surfactant administration.

T A Merritt1, D S Strayer, M Hallman

  • 1Department of Pediatrics, University of California-San Diego 92103.

Seminars in Perinatology
|July 1, 1988
PubMed
Summary

Human surfactant is immunogenic, forming immune complexes in infants and adults with respiratory distress syndrome (RDS). While short-term effects appear minimal, long-term consequences require further study.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Overview of treatment plan quality in a high dose rate prostate brachytherapy workflow.

Brachytherapy·2024
Same author

Follow-up study of the early, randomised paracetamol trial to preterm infants, found no adverse reactions at the two-years corrected age.

Acta paediatrica (Oslo, Norway : 1992)·2018
Same author

The gap between behavioral risk status and willingness to change behavior among healthcare professionals.

Perspectives in public health·2018
Same author

Intravenous paracetamol was associated with closure of the ductus arteriosus in extremely premature infants.

Acta paediatrica (Oslo, Norway : 1992)·2017
Same author

A systematic review and meta-analysis of long-term studies (five or more years) assessing maxillary sinus floor augmentation.

International journal of oral and maxillofacial surgery·2017
Same author

Randomized trial of early erythropoietin supplementation after preterm birth: Iron metabolism and outcome.

Early human development·2017

Area of Science:

  • Immunology
  • Pulmonology
  • Neonatology

Background:

  • Surfactant replacement therapy is crucial for neonatal respiratory distress syndrome (RDS).
  • Exogenous surfactant use is expanding to adult RDS, raising concerns about immunogenicity.
  • The immunogenic potential of human surfactant requires thorough investigation.

Purpose of the Study:

  • To determine if human surfactant is immunogenic.
  • To detect circulating surfactant-antisurfactant immune complexes in patients with RDS.
  • To assess the short-term and long-term implications of surfactant immunogenicity.

Main Methods:

  • Detection of surfactant-antisurfactant immune complexes in plasma samples from infants and adults with RDS.
  • Analysis of immune complex presence irrespective of exogenous surfactant treatment.

Related Experiment Videos

  • Clinical observation for adverse effects over a 2-4 year follow-up period.

    • Main Results:

    • Human surfactant was confirmed as immunogenic.
    • Circulating surfactant-antisurfactant immune complexes were detected in both infant and adult RDS patients.
    • No selective adverse effects were identified in the moderately long-term follow-up.
    • Exogenous surfactant therapy has significantly reduced mortality in preterm infants.

    Conclusions:

    • Human surfactant is immunogenic, and immune complexes can form in RDS patients.
    • While current data show no short-term adverse effects, long-term consequences remain unknown.
    • The benefits of surfactant therapy in neonatal RDS are well-established, but immunogenicity warrants careful consideration in adult RDS trials.